Ventricular assist device therapy in post-cardiotomy cardiogenic shock: Historical outcomes and current trends

6Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Ventricular assist device (VAD) therapy has been used successfully as a bridge to recovery, bridge to transplant and in the last decade as a destination therapy. The use of VAD for post-cardiotomy cardiogenic shock (PCCS) is not currently reported in national databases in the UK and Ireland. Data were collected through a telephone survey of chief perfusionists from all the cardiac surgery units in the UK and Ireland between October 2007 and October 2008. Approximately 28 000 adult cardiac surgical procedures were performed at 45 cardiac centres, of which 33 (73%) reported using VAD. The total number of patients supported was 66, of which 41% (n = 27) survived to be discharged home. About 42.5% (n = 28) died during VAD in place, and 16.5% died after successful weaning from VAD. Preferences for device types were Biomedicus (n = 25), Levitronix (n = 10), Sorin (n = 3), roller pump (n = 3) and Berlin heart (n = 2). Despite the reasonable survival rates after VAD use in post-cardiotomy heart failure, there are significant differences in their availability and individual's attitude towards their use. VAD use in PCCS should be prospectively documented in the audit returns of all the units, for further analysis and for generation of protocols. © The Author 2012. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

References Powered by Scopus

A decade of short-term outcomes in post-cardiac surgery ventricular assist device implantation: Data from the Society of Thoracic Surgeons' National Cardiac Database

99Citations
N/AReaders
Get full text

ABIOMED BVS 5000: Experience and potential advantages

83Citations
N/AReaders
Get full text

Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy

67Citations
N/AReaders
Get full text

Cited by Powered by Scopus

CentriMag® short-term ventricular assist as a bridge to solution in patients with advanced heart failure: Use beyond 30 days

55Citations
N/AReaders
Get full text

Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival

27Citations
N/AReaders
Get full text

The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK

24Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nasir, A., Bonde, P., & Graham, A. N. J. (2012, May). Ventricular assist device therapy in post-cardiotomy cardiogenic shock: Historical outcomes and current trends. Interactive Cardiovascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivr150

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

64%

Researcher 4

29%

Professor / Associate Prof. 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

81%

Agricultural and Biological Sciences 1

6%

Nursing and Health Professions 1

6%

Engineering 1

6%

Article Metrics

Tooltip
Mentions
References: 1

Save time finding and organizing research with Mendeley

Sign up for free